Head-to-head · WeighScore
Eden vs Get Thin MD
By GLP-1 ScorecardUpdated
Score comparison
Eden has the higher recorded score — 81.6/100 to 66.7/100.
Eden grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Eden advertises lower-priced compounded bundles, but its offer and linked membership and warranty terms need to be reconciled before purchase.
Before you choose
Get Thin MD does not publish a semaglutide price, so its Get Thin MD review sets out what it does disclose, while the Eden review explains the conditions attached to Eden's figure. The semaglutide cost page compares published rates across the field. Ask Get Thin MD for a written total before treating either one as the cheaper choice.
If neither one fits, Eden vs You + Me (He & She MD) and Effecty vs Get Thin MD compare each of them with another graded program, and the list of alternatives to Eden ranks the programs closest to Eden on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Eden | Get Thin MD |
|---|---|---|
| WeighScore | 81.6/100 | 66.7/100 |
| Grade | B− | C |
| Site position | #16 | #197 |
| Semaglutide | Advertised $99/mo bundle; linked membership terms conflict—confirm checkout | Confirm selected membership quote |
| Tirzepatide | Advertised $129/mo bundle; linked membership terms conflict—confirm checkout | Confirm selected membership quote |
| Coverage | All 50 states | Confirm coverage for your state |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #16 · B−
FDAWarning letter issued to Eden Health International Inc. dba Eden in June 2026. See the FDA warning-letter database.
Strengths
- Current compounded offer includes medication and support
- Homepage also advertises branded prescription pathways; eligibility and cost require confirmation
- Named pharmacy operation and partner network can be investigated
What to consider
- Linked membership terms describe a separate fee model
- Landing-page warranty and terms use different thresholds and conditions
- FDA warning history remains relevant; a new offer does not establish resolution
Strengths
- Membership terms describe included medication, supplies and shipping
What to consider
- The terms and refund policy describe different first-payment triggers
- The refund policy requires 72 hours’ notice before renewal
Featured provider
Eden
Eden scores 81.6/100 (B−). Eden advertises lower-priced compounded bundles, but its offer and linked membership and warranty terms need to be reconciled before purchase.
Commercial relationships affect this placement. The score comparison above is separate.
FDAWarning letter issued to Eden Health International Inc. dba Eden in June 2026. See the FDA warning-letter database.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.